Key facts
- It has raised $120K; the latest was Angel (individual) ($100K) in Jul 2025.
- Notable investors include Centech Accelerator, Lab2Market, Université de Montréal (University of Montreal), V1 Studio.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for mTatt
- ·The full record, as it builds
Funding rounds
No funding rounds for mTatt are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About mTatt
Developer of a fluorescent microtattoo system designed to enable painless and at-home health monitoring. The company offers microneedles shorter than one millimeter, discreet application, self-administration, and portable detection, enabling patients to track a range of biomarkers and gain actionable insights into their personal health.
- Sector
- Healthcare
- HQ
- Montreal, Canada
- Founded
- 2023
- Employees
- 2
- Website
- mtatt.co/
- Ownership
- Privately Held (backing)
mTatt doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in mTatt shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on mTatt in its N-PORT filings yet. We sweep new filings monthly.